Recurrent Neuroblastoma
Oncology·MeSH: Neuroblastoma
Prevalence
30.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Recurrent Neuroblastoma?
There are 2 clinical trials targeting Recurrent Neuroblastoma tracked by BioSniper.
What is the prevalence of Recurrent Neuroblastoma?
The estimated prevalence of Recurrent Neuroblastoma is approximately 30.0 per 100,000 population.
Deep-dive into Recurrent Neuroblastoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis